In Vitro and In Vivo Characterization of a Novel Nonsteroidal, Species-Specific Progesterone Receptor Modulator, PRA-910

作者: Z. Zhang , S. G. Lundeen , O. Slayden , Y. Zhu , J. Cohen

DOI: 10.1007/2789_2008_078

关键词:

摘要: The progesterone receptor (PR) is an important regulator of female reproduction. Consequently, PR modulators have found numerous pharmaceutical utilities in women's reproductive health. In the process identifying more receptor-specific and tissue-selective modulators, we discovered a novel nonsteroidal, 6-aryl benzoxazinone compound, PRA-910, that displays unique vitro vivo activities. PR/PRE reporter assay COS-7 cells, PRA-910 shows potent antagonist activity with IC50 value approximately 20 nM. alkaline phosphatase human breast cancer cell line T47D, partial at low concentrations also effective agonist higher (EC50 700 nM). binds to high affinity (K d=4 nM) was previously shown exhibit greater than 100-fold selectivity for versus other steroid receptors. adult ovariectomized rat, antagonist. It inhibits progesterone-induced uterine decidual response ED50 0.4 mg/kg, p.o., reverses suppression estradiol-induced complement C3 expression potency similar RU-486. nonhuman primate, however, agonist. effect on endometrial histology strongly resembles progesterone. This compound suppresses epithelial proliferation both estrogen endometrium as would. summary, structurally biologically selective modulator either or activity, depending context, concentration, species.

参考文章(23)
G.F. Allan, X Leng, S.Y. Tsai, N.L. Weigel, D.P. Edwards, M.J. Tsai, B.W. O'Malley, Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. Journal of Biological Chemistry. ,vol. 267, pp. 19513- 19520 ,(1992) , 10.1016/S0021-9258(18)41805-4
Alexandre Psychoyos, Hormonal control of ovoimplantation. Vitamins and Hormones Series. ,vol. 31, pp. 201- 256 ,(1973) , 10.1016/S0083-6729(08)60999-1
Yuji Tabata, Yumiko Iizuka, Rie Shinei, Ken-ichi Kurihara, Tsuneo Okonogi, Shigeru Hoshiko, Yasushi Kurata, Erratum to “CP8668, a novel orally active nonsteroidal progesterone receptor modulator with tetrahydrobenzindolone skeleton” [Eur. J. Pharmacol. 461 (2003) 73–78] European Journal of Pharmacology. ,vol. 465, pp. 299- ,(2003) , 10.1016/S0014-2999(03)01551-6
O D Slayden, R M Brenner, RU 486 action after estrogen priming in the endometrium and oviducts of rhesus monkeys (Macaca mulatta). The Journal of Clinical Endocrinology and Metabolism. ,vol. 78, pp. 440- 448 ,(1994) , 10.1210/JCEM.78.2.8106633
Puwen Zhang, Eugene A. Terefenko, Andrew Fensome, Zhiming Zhang, Yuan Zhu, Jeffrey Cohen, Richard Winneker, Jay Wrobel, John Yardley, Potent nonsteroidal progesterone receptor agonists: synthesis and SAR study of 6-aryl benzoxazines. Bioorganic & Medicinal Chemistry Letters. ,vol. 12, pp. 787- 790 ,(2002) , 10.1016/S0960-894X(02)00025-2
Kristof Chwalisz, Maria Claudia Perez, Deborah DeManno, Craig Winkel, Gerd Schubert, Walter Elger, Selective Progesterone Receptor Modulator Development and Use in the Treatment of Leiomyomata and Endometriosis Endocrine Reviews. ,vol. 26, pp. 423- 438 ,(2005) , 10.1210/ER.2005-0001
D P McDonnell, D L Clemm, T Hermann, M E Goldman, J W Pike, Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Molecular Endocrinology. ,vol. 9, pp. 659- 669 ,(1995) , 10.1210/MEND.9.6.8592512
Michal Melamed, Enrique Castaño, Angelo C. Notides, Shlomo Sasson, Molecular and Kinetic Basis for the Mixed Agonist/Antagonist Activity of Estriol Molecular Endocrinology. ,vol. 11, pp. 1868- 1878 ,(1997) , 10.1210/MEND.11.12.0025
Scott G Lundeen, Zhiming Zhang, Yuan Zhu, Jeffrey M Carver, Richard C Winneker, Rat uterine complement C3 expression as a model for progesterone receptor modulators: characterization of the new progestin trimegestone. The Journal of Steroid Biochemistry and Molecular Biology. ,vol. 78, pp. 137- 143 ,(2001) , 10.1016/S0960-0760(01)00091-7